Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

McGarty Named Chief Executive Officer of Fougera

By Pharmaceutical Processing | September 7, 2004

MELVILLE, NY (Sept. 7, 2004) – Pharmaceutical manufacturer Fougera announced that Paul B. McGarty took over as chief executive officer, effective September 1. In the role, McGarty will oversee all functional areas of the company, including sales,marketing, business development, scientific, and manufacturing for Fougera andPharmaDerm, the company said.

McGarty has more than 20 years of industry experience in major pharmaceutical companies, including Bristol-Myers Squibb and American HomeProducts (Wyeth), as well as start-up experience as chief executive officer of Aesgen, Inc. (a Mayo Clinic venture).

He began his pharmaceutical career with a degree in chemical engineering from the University of Rhode Island and worked at American Cyanamid (Lederle Laboratories) for 13 years in a variety of management assignments in manufacturing, marketing, sales and business development. He earned his M.B.A. from Pace University in New York.

At Bristol-Myers Squibb he was director of World-Wide Franchise Management and most recently he was senior vice president of U.S. operations at Taro Pharmaceuticals.

Fougera is a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmics. PharmaDerm manufactures, acquires, licenses and markets pharmaceutical products in targeted markets within the United States. Fougera and PharmaDerm are divisions of Altana Inc.

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE